Marimastat
Tocris Bioscience, part of Bio-Techne | Catalog # 2631
Broad spectrum MMP inhibitor
Key Product Details
Description
Broad spectrum MMP inhibitor
Alternative Names
BB 2516,Marimistat
Product Description
Marimastat is a broad spectrum inhibitor of MMPs (IC50 values are 3, 5, 6, 9 and 13 nM for MMP-9, MMP-1, MMP-2, MMP-14 and MMP-7 respectively). Inhibits peritoneal dissemination of human gastric cancer cells in vivo through inhibition of tumor angiogenesis.Product Specifications
Molecular Weight
331.41
Formula
C15H29N3O5
Storage
Store at -20°C
Purity
≥98% (HPLC)
Chemical Name
(2S,3R)-N4-[(1S)-2,2-Dimethyl-1-[(methylamino)carbonyl]propyl]-N1,2-dihydroxy-3-(2-methylpropyl)butanediamide
CAS Number
154039-60-8
PubChem ID
119031
InChI Key
OCSMOTCMPXTDND-OUAUKWLOSA-N
SMILES
O=C(NO)[C@@H](O)[C@H]([C@](N[C@@H]([C@](C)(C)C)C(NC)=O)=O)CC(C)C
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 33.14 | 100 |
Preparing Stock Solutions
for Marimastat
The following data is based on the product molecular weight 331.41
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 3.02 mL | 15.09 mL | 30.17 mL |
| 5 mM | 0.60 mL | 3.02 mL | 6.03 mL |
| 10 mM | 0.30 mL | 1.51 mL | 3.02 mL |
| 50 mM | 0.06 mL | 0.30 mL | 0.60 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Wada Reduced angiogenesis in peritoneal dissemination of gastric cancer through gelatinase inhibition. Clin.Exp.Metastasis 2003 PMID: 14524532
- Bjornland Matrix metalloproteinases participate in osteosarcoma invasion. J.Surg.Res. 2005 PMID: 16083752
- Rasmussen and McCann Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat. Pharmacol.Ther. 1997 PMID: 9364582
Product Specific Notices for Marimastat
For research use only
Loading...
Loading...
Loading...